EYLEA sol inj 2 mg/0.05ml flac
7680623970015
CH-62397
S01LA05
11.99.0.
Reimbursement limitations:
EYLEA7
Pour le traitement de la dégénérescence maculaire liée à l’âge exsudative (humide) – DMLA, d’une …
1 / 2
google
Details
- Product number
- 6239701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- afliberceptum 2 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.05 ml corresp. natrium 60 µg.
Articles (1)
Eylea, 2 mg/0,05 ml, Injektionslösung in Durchstechflasche
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
60.0 UG | Substance | HBESI |
Reimbursement information
Public price
CHF 936.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2012
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 62397
- Drug name
- Eylea, Injektionslösung zur intravitrealen Anwendung in einer Durchstechflasche
- Galenic form
- LSINJ
- ATC Code
- S01LA05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/10/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 11.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EYLEA sol inj 2 mg/0.05ml flac
- Description (DE)
- EYLEA Inj Lös 2 mg/0.05ml Durchstfl
- Market launch
- 29/10/2012
- Narcotic (BTM)
- No